Mark Eisner, Chief Medical Officer at FIBROGEN INC (FGEN), sold 24,866 shares at $20.20 ($516K) on 2023-03-10, disclosed to the SEC on 2023-03-10.
Open-market sale of $516k FGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.16 | 7,363 | $156K | 30.2% |
| 2 | $21.16 | 7,363 | $156K | 30.2% |
| 3 | $20.20 | 3,885 | $78K | 15.2% |
| 4 | $20.20 | 6,255 | $126K | 24.5% |
| Total | $20.77 avg | 24,866 | $516K | 100% |
| Filing → |
| VIR | SELL | 2025-07-17 | $57K | — | Filing → |
| FGEN | SELL | 2023-06-09 | $35K | — | Filing → |
| FGEN | SELL | 2023-06-05 | $21K | — | Filing → |